Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
Follow COR
Alert me
Cencora, Inc. (COR) Book value per share
Cencora, Inc.'s book value per share at the end of fiscal 2026 was 19.1×, up 111.4% from 9.0× in fiscal 2025. Over the past ten years it has ranged from −4.1× (fiscal 2020) to 19.1× (fiscal 2026) — the current reading is the highest in ten years. Cencora, Inc. ranks 2nd of 12 Medical Distribution companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | 19.1× | 111.41% |
| FY2025 | 9.0× | 127.43% |
| FY2024 | 4.0× | 20.46% |
| FY2023 | 3.3× | 862.30% |
| FY2022 | 0.3× | (87.95%) |
| FY2021 | 2.8× | — |
| FY2020 | −4.1× | — |
| FY2019 | 14.2× | 1.74% |
| FY2018 | 14.0× | 48.08% |
| FY2017 | 9.5× | (5.79%) |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 19.3× | 15.03% |
| Jun 2026 | 16.8× | (8.99%) |
| Mar 2026 | 18.4× | 70.75% |
| Dec 2025 | 10.8× | 19.72% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| HSIC Henry Schein, Inc. compare | 34.3× |
| COR Cencora, Inc. | 19.3× |
| COSM Cosmos Health Inc. compare | 0.3× |
| AHG Akso Health Group Sponsored ADR compare | 0.0× |
| FOCL FocalTherics compare | −0.1× |
| ACH Accendra Health, Inc. compare | −7.2× |
| CAH Cardinal Health, Inc. compare | −12.4× |
| YI 111, Inc. Sponsored ADR compare | −12.5× |
| MCK McKesson Corporation compare | −30.8× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement